The 2018 ESUR definition used in our study is consistent with the KDIGO criteria, and based on this standard, the incidence of CI-AKI was 9.5% in the TOL group versus 13.8% in the control group ( p = 0.306), which did not reach statistical significance.
← all excerpts
The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention.
1
—
—